Bio


Dr. Krish Bhadra is a board-certified, fellowship-trained interventional pulmonologist with Stanford Health Care and a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine, at Stanford University School of Medicine.

Dr. Bhadra specializes in advanced bronchoscopy, a procedure that uses a thin, flexible tube with a camera to examine the airways and collect tissue samples from the lungs. He focuses on image-guided and robotic techniques to evaluate lung lesions (abnormal areas of lung tissue). He was the first to perform bronchoscopy guided by digital tomosynthesis, an imaging technique that creates detailed, layered views of the lungs, and was an early adopter of cone-beam computed tomography (CT), which provides three-dimensional images to guide biopsies. His approach to patient care emphasizes careful listening, clear communication, and personalized treatment planning to help patients understand their options and make informed decisions.

Dr. Bhadra’s research focuses on making bronchoscopy more precise through advanced imaging, navigation technology, and new procedural techniques. His work includes integrating imaging with robotic bronchoscopy to guide instruments to lung lesions and improve biopsy accuracy. He also studies ways to account for changes in lung anatomy during procedures. He developed a lung-navigation ventilation protocol, a breathing strategy designed to help doctors locate and biopsy small lung lesions more accurately.

Dr. Bhadra has published research in numerous peer-reviewed journals, including the Journal of Bronchology & Interventional Pulmonology and Journal of Thoracic Disease. He has also contributed to international expert consensus recommendations on robotic-assisted bronchoscopy and frequently presents his work at national and international conferences.

Dr. Bhadra is a member of the American Association for Bronchology and Interventional Pulmonology (AABIP), the American Thoracic Society (ATS), and the Society for Advanced Bronchoscopy (SAB).

Clinical Focus


  • Pulmonary Disease

Academic Appointments


Boards, Advisory Committees, Professional Organizations


  • Member, SAB (2020 - Present)
  • Member, AABIP (2015 - Present)

Professional Education


  • Board Certification: American Association for Bronchology and Interventional Pulmonology, Interventional Pulmonology (2025)
  • Board Certification: American Board of Internal Medicine, Critical Care Medicine (2017)
  • Fellowship: University of Pennsylvania (2010) PA
  • Fellowship: University of Vermont Pulmonary Disease and Critical Care Fellowship (2010) VT
  • Board Certification: American Board of Internal Medicine, Pulmonary Disease (2009)
  • Residency: University of Vermont GME Programs (2007) VT
  • Medical Education: University of Miami (2004) FL

All Publications


  • American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series: Advanced Diagnostic Bronchoscopy in Lung Cancer: Closing the Diagnostic Gap and Beyond. Journal of bronchology & interventional pulmonology Channick, C. L., Ali, M. S., Benenson, D. M., Bhadra, K., Phan, A. T., Schwalk, A. J., Wong, C., Chrissian, A. A. 2026; 33 (4)

    Abstract

    The American Association of Bronchology and Interventional Pulmonology (AABIP) Essential Knowledge in Interventional Pulmonology Series aims to provide clinicians with concise, up-to-date reviews of key topics in the field, presented on a 3-year rotating cycle. The 2025 series focused on advanced diagnostic bronchoscopy. In this article, we provide an update on the bronchoscopic approach to malignant disease, examining whether navigational bronchoscopy has closed the diagnostic gap with transthoracic needle biopsy for peripheral pulmonary lesions, how advanced bronchoscopic technologies enable integrated diagnosis and mediastinal staging workflows, and whether these clinical benefits translate into meaningful economic value. These reviews are designed to complement the Essential Knowledge in Interventional Pulmonology Lecture Series delivered at the 2025 AABIP Annual Conference, which is available for viewing on the AABIP website: https://aabip.memberclicks.net/essential-knowledge-in-interventional-pulmonology-series.

    View details for DOI 10.1097/LBR.0000000000001090

    View details for PubMedID 42755264

  • Cone-beam computed tomography augmented-fluoroscopy-guided center-strike targeting during peripheral bronchoscopy: robotic <i>vs.</i> manual catheters JOURNAL OF THORACIC DISEASE Bhadra, K., Patel, P., Mahajan, A. K., Hogarth, D., Wagh, A. A. 2026
  • The match 2 study: Robotic assisted bronchoscopy with integrated imaging with assessment of digital tomosynthesis (DT) and augmented fluoroscopy (AF): Three-Dimensional accuracy as confirmed by cone beam computed tomography (CBCT). Respiratory medicine Mahajan, A. K., Duong, D. K., Cortes, J., Bhadra, K. 2026; 253: 108693

    Abstract

    Robotic-assisted bronchoscopy (RAB) with embedded digital tomosynthesis (DT) provides real-time, intraoperative nodule localization. This study examines the performance of RAB with embedded DT and integrated AF to achieve tool-in-lesion (TIL) confirmation via cone beam computer tomography (CBCT).This was a prospective, bicentric, single-arm, non-randomized observational trial. Thirty-one patients with peripheral pulmonary nodules underwent RAB with embedded DT. Navigation was guided by DT and augmented fluoroscopy (AF). Primary endpoints were successful navigation to target lesions and successful TIL as confirmed by CBCT. Secondary endpoints included diagnostic yield based on the strict Delphi consensus definition of diagnostic yield along with serious device or procedure-related adverse events.Thirty-one patients were enrolled across two sites. Thirty-one lung nodules were successfully biopsied. The mean lesion size measured by longest cross-sectional diameter was 16 mm (±6.7 mm). DT demonstrated TIL in 30 of 31 nodules (96.7 %), with one case resulting in tool-touching-lesion (TTL). Of the 30 nodules demonstrating TIL by DT, TIL was confirmed in 29 nodules by CBCT (concordance rate of 96.7 %). Overall TIL confirmed by CBCT was 29 of 31 nodules (93.5 %). A diagnosis was obtained in 30 of 31, resulting in a 96.7 % diagnostic yield by strict definition. Pneumothorax occurred in 1 of 31 cases (3 %).RAB with embedded DT demonstrated a high rate of TIL confirmed by CBCT. The strong concordance between the DT with AF and CBCT demonstrates the reliability of DT and AF for real-time intraprocedural guidance.

    View details for DOI 10.1016/j.rmed.2026.108693

    View details for PubMedID 41620189

  • World Expert Consensus Recommendations on Shape-Sensing Robotic-Assisted Bronchoscopy for the Diagnosis of Peripheral Pulmonary Lesions. Respiration; international review of thoracic diseases Brock, J. M., Fernandez-Bussy, S., Lee, A. Y., Chadha, R. M., Oberg, C., Ng, C. S., Chen, E., Folch, E., Zhang, H., Reisenauer, J. S., Bhadra, K., Pritchett, M. A., Shah, P. L., Li, S., Patel, P., Majid, A., Herth, F. J., Sun, J. 2026: 1-33

    Abstract

    Shape-sensing robotic-assisted bronchoscopy (ssRAB) represents a major advancement in the bronchoscopic evaluation of pulmonary nodules suspicious for malignancy. Its use has expanded across multiple countries and healthcare systems; however, no global consensus currently exists to guide clinical practice or address areas of uncertainty. This first world expert consensus was developed by an international panel of 18 specialists in interventional pulmonology and ssRAB, representing 13 hospitals across three continents. The process included a systematic literature review, followed by multiple rounds of structured questionnaires, sharing of clinical experience, and informed discussion, in order to identify key domains and establish consensus statements. A total of 38 recommendations were generated across domains including indications and contraindications, procedural set up, practical workflow, anesthesia considerations, diagnostic tools, training, reporting standards, and safety practices of ssRAB. Full consensus (100% agreement) was achieved for all 38 statements following three voting rounds and extensive discussion. This first international expert consensus provides comprehensive, evidence-informed guidance on the clinical use of ssRAB. It also highlights areas of ongoing uncertainty and can serve as a foundation for future research, education, and guideline development in this rapidly evolving field.

    View details for DOI 10.1159/000551026

    View details for PubMedID 41697930

  • Sustained breath-holds in bronchoscopy: a pause worth taking?- a narrative review JOURNAL OF THORACIC DISEASE Ratwani, A. P., Duke, J. D., Paez, R., Bridwell, G., Shojaee, S., Lentz, R. J., Eagle, S., Bhadra, K., Maldonado, F. 2025; 17 (11): 10541-10550
  • CT-augmented digital tomosynthesis image reconstruction in image-guided bronchoscopy interventions. Medical physics Saad, F., Frysch, R., Saalfeld, S., Kellnberger, S., Schulz, J., Fahrig, R., Bhadra, K., Nürnberger, A., Rose, G. 2025; 52 (3): 1468-1480

    Abstract

    Transbronchial needle biopsy is crucial for diagnosing lung cancer, yet its efficacy depends on accurately localizing the target lesion and biopsy needle. Digital tomosynthesis (DTS) is considered a promising imaging modality for guiding bronchoscopy procedures due to its low radiation dose and small footprint relative to cone-beam computed tomography (CBCT). However, the image quality of DTS is still not sufficient for an accurate guidance, mainly due to its limited-angle acquisition.Preoperative computed tomography (CT) scans are often performed prior to bronchoscopy interventions for diagnosis or to plan the procedure. The CT images are of high quality and are characterized by a high spatial resolution compared to intraoperative DTS images. These patient-specific prior CT images and the intraoperative DTS images share a fair amount of anatomical information. The main differences only stem from patient positioning and respiratory motion. When these differences are addressed properly, prior CT images augment intraoperative DTS image reconstruction with strong prior knowledge and potentially enhance DTS image quality.We propose in this work a prior-aided DTS image reconstruction technique leveraging prior CT images to improve DTS image quality. This technique is based on a recently published deformable CT-to-DTS image registration algorithm which is customized for bronchoscopy interventions. The main idea is to register a prior CT image to an intermediate DTS image reconstructed using the standard iterative algebraic reconstruction technique (ART), then to re-reconstruct the DTS image using ART and the registered prior CT image as a first estimation.The proposed prior-aided reconstruction method was tested on a physical phantom and six patient bronchoscopy datasets. Real DTS data acquired with a pseudo-linear (PL) scan geometry and simulated DTS data generated according to a spherical ellipse (SE) scan geometry were considered. Results evaluated qualitatively by visual inspection and quantitatively by computing Pearson's correlation (PC) with respect to the reference CBCT images suggest significant improvements in image quality using the prior-aided DTS reconstruction compared to the standard zero-initialized ART reconstruction. PC coefficients of the six patient datasets were on average 0.64 ± 0.13 $0.64\pm 0.13$ and 0.55 ± 0.13 $0.55\pm 0.13$ using a zero-initialized ART reconstruction with SE data and PL data, respectively, and 0.82 ± 0.09 $0.82\pm 0.09$ and 0.72 ± 0.09 $0.72\pm 0.09$ using the proposed prior-aided reconstruction with SE data and PL data, respectively.While the initial estimation in iterative reconstruction algorithms is often overlooked, we proved that initial estimation is of critical importance in DTS image reconstruction and we have demonstrated the profound advantages of integrating prior CT images in intraoperative DTS image reconstruction. CT-augmented DTS offers a viable alternative to CBCT in guiding bronchoscopy interventions at a fraction of the radiation dose. Further clinical studies are needed to validate improved diagnostic yield.

    View details for DOI 10.1002/mp.17551

    View details for PubMedID 39625122

    View details for PubMedCentralID PMC11880646

  • The Importance of Digital Lung Tomosynthesis in Overcoming Computed-Tomography-to-Body Divergence During Bronchoscopic Biopsies of Peripheral Lung Nodules SURGICAL TECHNOLOGY INTERNATIONAL-INTERNATIONAL DEVELOPMENTS IN SURGERY AND SURGICAL RESEARCH Mahajan, A., Cicenia, J., Hogarth, D. K., Ibrahim, O., Zhao, T., Badra, K. 2024; 44
  • High Tidal Volume, High Positive End Expiratory Pressure and Apneic Breath Hold Strategies (Lung Navigation Ventilation Protocol) With Cone Beam Computed Tomography Bronchoscopic Biopsy of Peripheral Lung Lesions: Results in 100 Patients. Journal of bronchology & interventional pulmonology Bhadra, K., Baleeiro, C., Patel, S., Condra, W., Bader, B. A., Setser, R. M., Youngblood, S. 2024; 31 (2): 105-116

    Abstract

    A dedicated anesthesia protocol for bronchoscopic lung biopsy-lung navigation ventilation protocol (LNVP)-specifically designed to mitigate atelectasis and reduce unnecessary respiratory motion, has been recently described. LNVP demonstrated significantly reduced dependent ground glass, sublobar/lobar atelectasis, and atelectasis obscuring target lesions compared with conventional ventilation.In this retrospective, single-center study, we examine the impact of LNVP on 100 consecutive patients during peripheral lung lesion biopsy. We report the incidence of atelectasis using cone beam computed tomography imaging, observed ventilatory findings, anesthesia medications, and outcomes, including diagnostic yield, radiation exposure, and complications.Atelectasis was observed in a minority of subjects: ground glass opacity atelectasis was seen in 30 patients by reader 1 (28%) and in 18 patients by reader 2 (17%), with good agreement between readers (κ = 0.78). Sublobar/lobar atelectasis was observed in 23 patients by reader 1 and 26 patients by reader 2, also demonstrating good agreement (κ = 0.67). Atelectasis obscured target lesions in very few cases: 0 patients (0%, reader 1) and 3 patients (3%, reader 2). Diagnostic yield was 85.9% based on the AQuIRE definition. Pathology demonstrated 57 of 106 lesions (54%) were malignant, 34 lesions (32%) were benign, and 15 lesions (14%) were nondiagnostic.Cone beam computed tomography images confirmed low rates of atelectasis, high tool-in-lesion confirmation rate, and high diagnostic yield. LNVP has a similar safety profile to conventional bronchoscopy. Most patients will require intravenous fluid and vasopressor support. Further study of LNVP and other ventilation protocols are necessary to understand the impact of ventilation protocols on bronchoscopic peripheral lung biopsy.

    View details for DOI 10.1097/LBR.0000000000000938

    View details for PubMedID 37459049

    View details for PubMedCentralID PMC10984636

  • A Cone Beam CT Bronchoscopy Study of the Ultrathin Cryoprobe for Biopsy of Peripheral Lung Lesions. Journal of bronchology & interventional pulmonology Bhadra, K., Setser, R. M., Condra, W., Bader, B. A., David, S. 2024; 31 (2): 117-125

    Abstract

    Compared with the standard cryoprobe, the novel ultrathin 1.1 mm cryoprobe (UTCP) has improved ergonomics, shape memory, and flexibility. The performance of UTCP has demonstrated promising results in several small trials.In this single-center, retrospective review, we examine 200 (N=200) consecutive patients referred for cone beam CT bronchoscopic biopsy of peripheral lung lesions. We utilized an extended multimodality approach, including transbronchial needle aspirate, brush, traditional forces biopsies, UTCP biopsies, and BAL. We analyzed tool in lesion, tool touch lesion, center strike rates, and diagnostic yield. We assessed for molecular adequacy and analyzed safety.A total of 222 lesions were biopsied. We achieved a tool in lesion or tool touch lesion confirmation for all biopsy attempts (100%) and a center strike rate of 68%. AQuIRE diagnostic yield was 90%, with 60% malignant, 30% benign lung nodules, and 10% nondiagnostic. UTCP was diagnostic in 3.6 % of peripheral lung lesions biopsies when all other modalities were nondiagnostic; thus, raising our overall diagnostic yield from 86.4% to 90.1%. Our analysis demonstrates superior adequacy for molecular analysis for histologic samples (TBBX or UTCP) versus cytologic samples (FNA) ( P <0.001). Three patients (1.5%) had a pneumothorax, and 1 patient (0.5%) had moderate bleeding.UTCP was diagnostic in 3.6% of peripheral lung lesions when all other modalities were nondiagnostic. In the setting of CBCT guidance, UTCP has a similar safety profile to standard biopsy tools. Future trials are warranted to assess UTCP and its impact on peripheral lung lesion biopsies.

    View details for DOI 10.1097/LBR.0000000000000936

    View details for PubMedID 37450607

    View details for PubMedCentralID PMC10984630

  • "Tool-in-lesion" Accuracy of Galaxy System-A Robotic Electromagnetic Navigation BroncHoscopy With Integrated Tool-in-lesion-Tomosynthesis Technology: The MATCH Study. Journal of bronchology & interventional pulmonology Bhadra, K., Rickman, O. B., Mahajan, A. K., Hogarth, D. K. 2024; 31 (1): 23-29

    Abstract

    The Galaxy System (Noah Medical) is a novel robotic endoluminal platform using electromagnetic navigation combined with integrated tomosynthesis technology and augmented fluoroscopy. It provides intraprocedural imaging to correct computerized tomography (CT) to body divergence and novel confirmation of tool-in-lesion (TIL). The primary aim of this study was to assess the TIL accuracy of the robotic bronchoscope with integrated digital tomosynthesis and augmented fluoroscopy.Four operators conducted the experiment using 4 pigs. Each physician performed between 4 and 6 nodule biopsies for 20 simulated lung nodules with purple dye and a radio pacifier. Using Galaxy's "Tool-in-Lesion Tomography (TOMO+)" with augmented fluoroscopy, the physician navigated to the lung nodules, and a tool (needle) was placed into the lesion. TIL was defined by the needle in the lesion determined by cone-beam CT.The lung nodule's average size was 16.3 ± 0.97 mm and was predominantly in the lower lobes (65%). All 4 operators successfully navigated to all (100%) of the lesions in an average of 3 minutes and 39 seconds. The median number of tomosynthesis sweeps was 3 and augmented fluoroscopy was utilized in most cases (17/20 or 85%). TIL after the final TOMO sweep was 95% (19/20) and tool-touch-lesion was 5% (1/20). Biopsy yielding purple pigmentation was also 100% (20/20).The Galaxy System demonstrated successful digital TOMO confirmed TIL success in 95% (19/20) of lesions and tool-touch-lesion in 5% (1/20) as confirmed by cone-beam CT. Successful diagnostic yield was achieved in 100% (20/20) of lesions as confirmed by intralesional pigment acquisition.

    View details for DOI 10.1097/LBR.0000000000000923

    View details for PubMedID 37072895

    View details for PubMedCentralID PMC10763708

  • Out of the Box Thinking: Prone Bronchoscopy to Reduce Atelectasis. Journal of bronchology & interventional pulmonology Bhadra, K., Condra, W., Setser, R. M. 2022; 29 (4): e57-e60

    View details for DOI 10.1097/LBR.0000000000000822

    View details for PubMedID 35822718

  • NAVIGATE 24-Month Results: Electromagnetic Navigation Bronchoscopy for Pulmonary Lesions at 37 Centers in Europe and the United States. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Folch, E. E., Bowling, M. R., Pritchett, M. A., Murgu, S. D., Nead, M. A., Flandes, J., Krimsky, W. S., Mahajan, A. K., LeMense, G. P., Murillo, B. A., Bansal, S., Lau, K., Gildea, T. R., Christensen, M., Arenberg, D. A., Singh, J., Bhadra, K., Hogarth, D. K., Towe, C. W., Lamprecht, B., Bezzi, M., Mattingley, J. S., Hood, K. L., Lin, H., Wolvers, J. J., Khandhar, S. J. 2022; 17 (4): 519-531

    Abstract

    Electromagnetic navigation bronchoscopy (ENB) is a minimally invasive, image-guided approach to access lung lesions for biopsy or localization for treatment. However, no studies have reported prospective 24-month follow-up from a large, multinational, generalizable cohort. This study evaluated ENB safety, diagnostic yield, and usage patterns in an unrestricted, real-world observational design.The NAVIGATE single-arm, pragmatic cohort study (NCT02410837) enrolled subjects at 37 academic and community sites in seven countries with prospective 24-month follow-up. Subjects underwent ENB using the superDimension navigation system versions 6.3 to 7.1. The prespecified primary end point was procedure-related pneumothorax requiring intervention or hospitalization.A total of 1388 subjects were enrolled for lung lesion biopsy (1329; 95.7%), fiducial marker placement (272; 19.6%), dye marking (23; 1.7%), or lymph node biopsy (36; 2.6%). Concurrent endobronchial ultrasound-guided staging occurred in 456 subjects. General anesthesia (78.2% overall, 56.6% Europe, 81.4% United States), radial endobronchial ultrasound (50.6%, 4.0%, 57.4%), fluoroscopy (85.0%, 41.7%, 91.0%), and rapid on-site evaluation use (61.7%, 17.3%, 68.5%) differed between regions. Pneumothorax and bronchopulmonary hemorrhage occurred in 4.7% and 2.7% of subjects, respectively (3.2% [primary end point] and 1.7% requiring intervention or hospitalization). Respiratory failure occurred in 0.6%. The diagnostic yield was 67.8% (range: 61.9%-70.7%; 55.2% Europe, 69.8% United States). Sensitivity for malignancy was 62.6%. Lung cancer clinical stage was I to II in 64.7% (55.3% Europe, 65.8% United States).Despite a heterogeneous cohort and regional differences in procedural techniques, ENB demonstrates low complications and a 67.8% diagnostic yield while allowing biopsy, staging, fiducial placement, and dye marking in a single procedure.

    View details for DOI 10.1016/j.jtho.2021.12.008

    View details for PubMedID 34973418

  • Lung Navigation Ventilation Protocol to Optimize Biopsy of Peripheral Lung Lesions. Journal of bronchology & interventional pulmonology Bhadra, K., Setser, R. M., Condra, W., Pritchett, M. A. 2022; 29 (1): 7-17

    Abstract

    Computed tomography-to-body divergence caused by respiratory motion, atelectasis, diaphragmatic motion and other factors is an obstacle to peripheral lung biopsies. We examined a conventional ventilation strategy versus a lung navigation ventilation protocol (LNVP) optimized for intraprocedural 3-dimensional image acquisition and bronchoscopic biopsy of peripheral lung nodules.A retrospective, single center study was conducted in consecutive subjects with peripheral lung lesions measuring <30 mm. Effects of ventilation strategies including atelectasis and tool-in-lesion confirmation were assessed using cone beam computed tomography images. Diagnostic yield was also evaluated. Complications were assessed through 7 days.Fifty subjects were included (25 per group) with 27 nodules in the conventional group and 25 nodules in the LNVP group. Atelectasis was assessed by 2 blinded readers: [reader 1 (R1) and reader 2 (R2)]. Atelectasis was more prevalent in the conventional ventilation group, both for dependent atelectasis (R1: 64% and R2: 68% vs. R1: 36% and R2: 16%, P=0.00014) and sublobar/lobar atelectasis (R1: 48% and R2: 56% vs. R1: 20% and R2: 32%, P=0.01). Similarly, the target lesion was obscured due to atelectasis more often in the conventional ventilation group (R1: 36% and R2: 36% vs. R1: 4% and R2: 8%, P=0.01). Diagnostic yield was 70% for conventional ventilation and 92% for LNVP (P=0.08).LNVP demonstrated markedly reduced dependent and sublobar/lobar atelectasis and lesions either partially or completely obscured by atelectasis compared with conventional ventilation. Future prospective studies are necessary to understand the impact of protocolized ventilation strategies for bronchoscopic biopsy of peripheral lung lesions.

    View details for DOI 10.1097/LBR.0000000000000756

    View details for PubMedID 33734150

  • Anesthesia considerations to reduce motion and atelectasis during advanced guided bronchoscopy. BMC pulmonary medicine Pritchett, M. A., Lau, K., Skibo, S., Phillips, K. A., Bhadra, K. 2021; 21 (1): 240

    Abstract

    Partnership between anesthesia providers and proceduralists is essential to ensure patient safety and optimize outcomes. A renewed importance of this axiom has emerged in advanced bronchoscopy and interventional pulmonology. While anesthesia-induced atelectasis is common, it is not typically clinically significant. Advanced guided bronchoscopic biopsy is an exception in which anesthesia protocols substantially impact outcomes. Procedure success depends on careful ventilation to avoid excessive motion, reduce distortion causing computed tomography (CT)-to-body-divergence, stabilize dependent areas, and optimize breath-hold maneuvers to prevent atelectasis. Herein are anesthesia recommendations during guided bronchoscopy. An FiO2 of 0.6 to 0.8 is recommended for pre-oxygenation, maintained at the lowest tolerable level for the entire the procedure. Expeditious intubation (not rapid-sequence) with a larger endotracheal tube and non-depolarizing muscle relaxants are preferred. Positive end-expiratory pressure (PEEP) of up to 10-12 cm H2O and increased tidal volumes help to maintain optimal lung inflation, if tolerated by the patient as determined during recruitment. A breath-hold is required to reduce motion artifact during intraprocedural imaging (e.g., cone-beam CT, digital tomosynthesis), timed at the end of a normal tidal breath (peak inspiration) and held until pressures equilibrate and the imaging cycle is complete. Use of the adjustable pressure-limiting valve is critical to maintain the desired PEEP and reduce movement during breath-hold maneuvers. These measures will reduce atelectasis and CT-to-body divergence, minimize motion artifact, and provide clearer, more accurate images during guided bronchoscopy. Following these recommendations will facilitate a successful lung biopsy, potentially accelerating the time to treatment by avoiding additional biopsies. Application of these methods should be at the discretion of the anesthesiologist and the proceduralist; best medical judgement should be used in all cases to ensure the safety of the patient.

    View details for DOI 10.1186/s12890-021-01584-6

    View details for PubMedID 34273966

    View details for PubMedCentralID PMC8286573

  • Augmented Fluoroscopy: A New and Novel Navigation Platform for Peripheral Bronchoscopy. Journal of bronchology & interventional pulmonology Cicenia, J., Bhadra, K., Sethi, S., Nader, D. A., Whitten, P., Hogarth, D. K. 2021; 28 (2): 116-123

    Abstract

    The diagnosis of lung nodules continues to be a challenge. Confirmed diagnosis allows appropriate treatment for cancers and allows avoidance of more invasive procedures for proven noncancers. Currently, available lung biopsy technologies each have their own limitations, which affect the ability to successfully navigate to a suspicious nodule and to collect a diagnostic sample. Additional advancements in endobronchial navigation, localization, and guided biopsy are needed to obtain higher rates of definitive diagnosis for lung nodules.This is a prospective, multicenter study that assessed the localization success rate and diagnostic yield of bronchoscopies guided only by the LungVision platform. Physicians navigated to pulmonary nodules according to a proposed pathway and verified nodule location using radial endobronchial ultrasound before the biopsy.Fifty-five patients were enrolled in the study. Two patients had >1 nodule that was evaluated on the day of the procedure. During bronchoscopy, the nodule localization success rate was 93%. The overall diagnostic yield measured the day of the procedure, based on the immediate rapid on-site pathology report, was 75.4%.LungVision provides reliable navigation and ability to biopsy pulmonary nodules with an acceptable success rate. The platform demonstrates a high localization rate of pulmonary nodules.

    View details for DOI 10.1097/LBR.0000000000000722

    View details for PubMedID 33105419

  • Electromagnetic Navigation Bronchoscopy With Tomosynthesis-based Visualization and Positional Correction: Three-dimensional Accuracy as Confirmed by Cone-Beam Computed Tomography. Journal of bronchology & interventional pulmonology Pritchett, M. A., Bhadra, K., Mattingley, J. S. 2021; 28 (1): 10-20

    Abstract

    Electromagnetic navigation bronchoscopy (ENB) aids in lung lesion biopsy. However, anatomic divergence between the preprocedural computed tomography (CT) and the actual bronchial anatomy during the procedure can limit localization accuracy. An advanced ENB system has been designed to mitigate CT-to-body divergence using a tomosynthesis-based software algorithm that enhances nodule visibility and allows for intraprocedural local registration.A prospective, 2-center study was conducted in subjects with single peripheral lung lesions ≥10 mm to assess localization accuracy of the superDimension navigation system with fluoroscopic navigation technology. Three-dimensional accuracy was confirmed by cone-beam computed tomography. Complications were assessed through 7 days.Fifty subjects were enrolled (25 per site). Lesions were <20 mm in 61.2% (30/49). A bronchus sign was present in 53.1% (26/49). Local registration was completed in 95.9% (47/49). Three-dimensional target overlap (primary endpoint) was achieved in 59.6% (28/47) and 83.0% (39/47) before and after location correction, respectively. Excluding subjects with unevaluable video files, target overlap was achieved 68.3% (28/41) and 95.1% (39/41), respectively. Malignant results were obtained in 53.1% (26/49) by rapid on-site evaluation and 61.2% (30/49) by final pathology of the ENB-aided sample. Diagnostic yield was not evaluated. Procedure-related complications were pneumothorax in 1 subject (no chest tube required) and scant hemoptysis in 3 subjects (no interventions required).ENB with tomosynthesis-based fluoroscopic navigation improved the 3-dimensional convergence between the virtual target and actual lung lesion as confirmed by cone-beam computed tomography. Future studies are necessary to understand the impact of this technology on diagnostic yield.

    View details for DOI 10.1097/LBR.0000000000000687

    View details for PubMedID 32412920

    View details for PubMedCentralID PMC7742212

  • Cone beam CT imaging for bronchoscopy: a technical review JOURNAL OF THORACIC DISEASE Setser, R., Chintalapani, G., Bhadra, K., Casal, R. F. 2020; 12 (12): 7416-7428
  • Managing Lung Nodules Using Telemedicine and Molecular Biomarkers During the COVID-19 Pandemic. Chest Springmeyer, S. C., Jett, J., Bhadra, K., Kheir, F., Majid, A. 2020; 158 (4): 1794-1795

    View details for DOI 10.1016/j.chest.2020.05.574

    View details for PubMedID 33036105

    View details for PubMedCentralID PMC7533686

  • Prognostic performance of proteomic testing in advanced non-small cell lung cancer: a systematic literature review and meta-analysis. Current medical research and opinion Leal, T. A., Argento, A. C., Bhadra, K., Hogarth, D. K., Grigorieva, J., Hartfield, R. M., McDonald, R. C., Bonomi, P. D. 2020; 36 (9): 1497-1505

    Abstract

    Timely assessment of patient-specific prognosis is critical to oncology care involving a shared decision-making approach, but clinical prognostic factors traditionally used in NSCLC have limitations. We examine a proteomic test to address these limitations.This study examines the prognostic performance of the VeriStrat blood-based proteomic test that measures the inflammatory disease state of patients with advanced NSCLC. A systematic literature review (SLR) was performed, yielding cohorts in which the hazard ratio (HR) was reported for overall survival (OS) of patients with VeriStrat Poor (VSPoor) test results versus VeriStrat Good (VSGood). A study-level meta-analysis of OS HRs was performed in subgroups defined by lines of therapy and treatment regimens.Twenty-four cohorts met SLR criteria. Meta-analyses in five subgroups (first-line platinum-based chemotherapy, second-line single-agent chemotherapy, first-line EGFR-tyrosine kinase inhibitor (TKI) therapy, and second- and higher-line TKI therapy, and best supportive care) resulted in statistically significant (p ≤ .001) summary effect sizes for OS HRs of 0.42, 0.54, 0.41, 0.52, and 0.50, respectively, indicating increased OS by about two-fold for patients who test VSGood. No significant heterogeneity was seen in any subgroup (p > .05).Advanced NSCLC patients classified VSGood have significantly longer OS than those classified VSPoor. The summary effect size for OS HRs around 0.4-0.5 indicates that the expected median survival of those with a VSGood classification is approximately 2-2.5 times as long as those with VSPoor. The robust prognostic performance of the VeriStrat test across various lines of therapy and treatment regimens has clinical implications for treatment shared decision-making and potential for novel treatment strategies.

    View details for DOI 10.1080/03007995.2020.1790346

    View details for PubMedID 32615813

  • Virtual or reality: divergence between preprocedural computed tomography scans and lung anatomy during guided bronchoscopy JOURNAL OF THORACIC DISEASE Pritchett, M. A., Bhadra, K., Calcutt, M., Folch, E. 2020; 12 (4): 1595-1611
  • Secondary carina Y-stent placement for post-lung-transplant bronchial stenosis. Journal of bronchology & interventional pulmonology Lee, H. J., Puchalski, J., Sterman, D. H., Bhadra, K., Kumar, R., Gillespie, C. T., Haas, A. R. 2012; 19 (2): 109-14

    Abstract

    Post-lung-transplant bronchial stenosis (TBS) may cause significant morbidity and mortality. Although often transiently relieved by balloon bronchoplasty, stents may be required for long-term airway patency. We report a series of lung transplant patients in whom a silicone Y-stent was placed at the secondary carina for long-standing relief of post-transplant-airway stenosis.Six lung transplant patients received 10 silicone Y-stents in the secondary carina over the past 18 months for post-transplant-bronchial stenosis. All patients failed other interventional therapeutic procedures including balloon bronchoplasty and/or conventional stenting before secondary carina Y-stent placement. Patient data include 12 months' follow-up after Y-stent insertion. The number of procedures and the interval between procedures was examined before and after secondary carina silicone Y-stent placement.There was a significantly prolonged therapeutic effect accomplished in these patients after secondary carina Y-stent placement with the exception of 1 patient. When stents were tolerated by the patient, the mean number of procedures before secondary carina Y-stent insertion was 15.6, but only 4.8 after Y-stent insertion. The number of days between procedures was 24.5 days before the Y-stent insertion and 85.8 days after the Y-stent insertion. There were no complications in any patient during secondary carina Y-stent insertion.Secondary carina silicone Y-stent placement in TBS decreased the number of therapeutic procedures and provided longer-lasting results in most posttransplant patients who required multiple prior procedures for TBS.

    View details for DOI 10.1097/LBR.0b013e31824f143f

    View details for PubMedID 23207352

  • A Bronchoscopic Oddity <i>Nodular Tracheobronchial Amyloidosis</i> JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY Bhadra, K., Butnor, K. J., Davis, G. S. 2010; 17 (3): 248-252